Predictors of retention in HIV care among a national cohort of US veterans

HIV Clinical Trials

Volumn 10, Issue 5, 2009, Pages 299-305

  Giordano, Thomas P ^a,b   Hartman, Christine ^a,b   Gifford, Allen L ^c   Backus, Lisa I ^d   Morgan, Robert O ^a,b,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adherence; Cohort study; HIV AIDS; Survival; Veterans affairs

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CD4+ T LYMPHOCYTE; COMORBIDITY; DRUG USE; ETHNICITY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PATIENT COMPLIANCE; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING; SURVIVAL; VETERAN;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; CONTINUITY OF PATIENT CARE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UNITED STATES; VETERANS;

EID: 70450212559     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1005-299     Document Type: Article

References (20)

1. Kleeberger CA, Buechner J, Palella F, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS. 2004;18(4):683-688.
2. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care. 2004;16(4):501-506.
3. Giordano TP, White AC Jr, Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003;32(4):399-405.
4. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131(2):81-87.
5. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunoDeficiency virus drug resistance. Clin Infect Dis. 2003;37(8):1112-1118.
6. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493- 1499.
7. Park WB, Choe PG, Kim SH, et al. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients. J Intern Med. 2007;261(3):268-275.
8. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48(2):248-256.
9. Jones JL, Hanson D, Dworkin M, et al. Surveillance for AIDS-defi ning opportunistic illnesses, 1992-1997. CDC Surveillance Summaries, MMWR. 1999;48(No.).
10. Centers for Disease Control and Prevention. 1993 revised classifi cation system for HIV infection and expanded surveillance case defi nition for AIDS among adolescents and adults. MMWR. 1992;41(RR-17).
11. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-1182.
12. Whetten K, Leserman J, Whetten R, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health. 2006;96(4):716-721.
13. Clark A, Mayben JK, Hartman C, Kallen MA, Giordano TP. Conspiracy beliefs about HIV infection are common but not associated with delayed diagnosis or adherence to care. AIDS Patient Care STDS. 2008;22(9):753-759.
14. Ross MW, Essien EJ, Torres I. Conspiracy beliefs about the origin of HIV/AIDS in four racial/ethnic groups. J Acquir Immune Defic Syndr. 2006;41(3):342-344.
15. Mugavero MJ, Lin H-Y, Allison JJ, et al. Racial disparities in HIV virologic failure: Do missed visits matter? J Acquir Immune Defic Syndr. 2009;50(1):100-108.
16. Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis. 2007;44(11):1500-1502.
17. Naar-King S, Bradford J, Coleman S, Green-Jones M, Cabral H, Tobias C. Retention in care of persons newly diagnosed with HIV: outcomes of the Outreach Initiative. AIDS Patient Care STDS. 2007;21(Suppl 1):S40-48.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
19. Menke TJ, Giordano TP, Rabeneck L. Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy. J Natl Med Assoc. 2003;95(9):853-861.
20. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR-14).